Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics. Brillac C, Semiond D, Oprea C, Baruchel A, et al. Cancer Chemother Pharmacol 2025;95:116.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brillac C, Semiond D, Oprea C, Baruchel A, et al. Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics. Cancer Chemother Pharmacol 2025;95:116.
PMID: 41331127